Trial intelligence / Profile preview

Fluid Kinetics in Diabetic Ketoacidosis

NCT02172092Completed

Start
Aug 2014
Primary completion
Dec 2018
Countries
1
01

Overview

Open-label trial of sodium chloride in diabetic ketoacidosis (DKA). Primary endpoint: Extracellular volume at 120 minutes. Started Aug 2014; status: completed.

02

Drugs

sodium chloride
03

Conditions

diabetic ketoacidosis (DKA)

Beyond the preview

Go deeper on NCT02172092.

Study design, results and competitive context are available in the Gosset platform where reported.

Study design & results

Available in the Gosset platform where reported.

Competitive context

Available in the Gosset platform where reported.

Bring the full picture into focus.

See how Gosset can support your research on NCT02172092.

Gosset Free

Get started with Gosset.

Enter your corporate email.

Work email preferred.

Book a call